Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy

1. Burgaz, S.
2. Navarro, E.
3. Rodríguez-Carreiro, S.
4. Navarrete, C.
5. Garrido-Rodríguez, M.
6. Lastres-Becker, I.
7. Chocarro, J.
8. Lanciego, J.L.
9. Muñoz, E.
10. Fernández-Ruiz, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1186/S12993-024-00256-9 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus